| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
HOUSTON—According to researchers at the University of Texas MD Anderson Cancer Center and the Houston Methodist Cancer Center, using an antibody to block a protein secreted by fibrous tissues in tumors can inhibit ovarian and pancreatic cancer—in mouse models, at least—by reducing fibrosis and blood vessel formation. They published their findings recently in the journal Clinical Cancer Research.
 
The team also found that the antibody developed to block the microfibril associated protein 5 (MFAP5), which exists similarly in humans and mice, also enhances the effectiveness of chemotherapy against the tumors.
 
“MFAP5 promotes fibrosis in ovarian and pancreatic cancers, and fibrosis promotes progression and reduces survival of people with these cancers,” said Dr. Samuel Mok, a professor of gynecologic oncology and reproductive medicine at MD Anderson. “By blocking this secretory protein with an antibody, we can treat the tumor by targeting multiple cellular types—fibroblasts and blood vessels—in the tumor microenvironment.”
 
The researchers are taking steps to advance the approach to clinical trials, including commercial manufacture of the antibody and additional toxicity studies.
 
“As with digital medicine, we are seeing more such marriage of data analysis and modeling with experimental biology to derive new understanding of disease mechanisms and novel drug targets,” noted the co-corresponding author, Dr. Stephen T.C. Wong, who is a professor and the associate director at Houston Methodist Cancer Center.

Related Topics

Published In

Volume 15 - Issue 11 | November 2019

November 2019

November 2019 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
A starry night sky reflected over calm water, symbolizing the discovery of hidden patterns in complex systems.

Technology Guide: Spatial biology techniques

Discover essential strategies and expert insights to navigate the expanding world of spatial biology.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue